Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eidos Therapeutics Inc (EIDX)

Eidos Therapeutics Inc (EIDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,479,669
  • Shares Outstanding, K 38,663
  • Annual Sales, $ 26,690 K
  • Annual Income, $ -37,840 K
  • 60-Month Beta -0.55
  • Price/Sales 128.50
  • Price/Cash Flow N/A
  • Price/Book 27.92
Trade EIDX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.77
  • Number of Estimates 3
  • High Estimate -0.74
  • Low Estimate -0.81
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -50.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.38 +29.73%
on 10/30/20
91.85 -2.01%
on 11/27/20
+16.62 (+22.65%)
since 10/27/20
3-Month
38.96 +131.01%
on 09/04/20
91.85 -2.01%
on 11/27/20
+48.21 (+115.36%)
since 08/27/20
52-Week
28.39 +217.01%
on 03/16/20
91.85 -2.01%
on 11/27/20
+34.24 (+61.41%)
since 11/27/19

Most Recent Stories

More News
Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - STND, EIDX, WTRE, EV

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

STND : 32.82 (-0.15%)
EIDX : 90.00 (+1.45%)
WTRE : 34.74 (+0.14%)
EV : 68.72 (+0.20%)
Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, BMCH, BLDR, CIT, EV, EIDX, NAV, STND and WTRE

, /PRNewswire/ --

EIDX : 90.00 (+1.45%)
ARA : 11.42 (-0.17%)
BMCH : 49.55 (+1.31%)
BLDR : 37.93 (+1.61%)
CIT : 34.46 (-1.51%)
EV : 68.72 (+0.20%)
BBIO : 49.13 (+1.36%)
NAV : 44.06 (+0.11%)
STND : 32.82 (-0.15%)
WTRE : 34.74 (+0.14%)
Alexion's (ALXN) Ultomiris IV Formulation Gets EC Approval

Alexion's (ALXN) new 100 mg/mL intravenous (IV) formulation of Ultomiris gets EC approval for PNH and aHUS.

ALXN : 123.83 (+0.73%)
HALO : 40.23 (-2.21%)
VNDA : 12.41 (+2.48%)
EIDX : 90.00 (+1.45%)
WeissLaw LLP Reminds PTI, MVC, and EIDX Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

PTI : 1.0900 (+3.81%)
MVC : 8.48 (-0.35%)
EIDX : 90.00 (+1.45%)
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - GLIBA, EIDX, EV, PNM

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

GLIBA : 91.31 (+0.30%)
EIDX : 90.00 (+1.45%)
EV : 68.72 (+0.20%)
PNM : 49.09 (-0.04%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, CEIX, PNM, and EIDX Mergers

EQNX::TICKER_START (NYSE:CXO),(NYSE:CEIX),(NYSE:PNM),(NASDAQ:EIDX), EQNX::TICKER_END

CXO : 62.02 (-2.13%)
CEIX : 5.68 (-5.65%)
PNM : 49.09 (-0.04%)
EIDX : 90.00 (+1.45%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm - STND, EIDX, WTRE, EV

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

STND : 32.82 (-0.15%)
EIDX : 90.00 (+1.45%)
WTRE : 34.74 (+0.14%)
EV : 68.72 (+0.20%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds MVC, MOBL, GMHI, and EIDX Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

MVC : 8.48 (-0.35%)
MOBL : 7.03 (unch)
GMHI : 15.39 (+13.25%)
EIDX : 90.00 (+1.45%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, EIDX, CEIX, and PNM Mergers

EQNX::TICKER_START (NASDAQ:EIDX),(NYSE:PNM),(NASDAQ:IPHI),(NYSE:CEIX), EQNX::TICKER_END

IPHI : 152.21 (+1.48%)
EIDX : 90.00 (+1.45%)
CEIX : 5.68 (-5.65%)
PNM : 49.09 (-0.04%)
Lifshitz Law Firm, P.C. Announces Investigation of CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited

NEW YORK, NY / ACCESSWIRE / November 13, 2020 /

CIT : 34.46 (-1.51%)
EIDX : 90.00 (+1.45%)
WTRE : 34.74 (+0.14%)
YIN : 7.25 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It discovers and develops novel oral therapy for the treatment of diseases caused by transthyretin amyloidosis. Eidos Therapeutics, Inc. is based in San Francisco, United States.

See More

Key Turning Points

2nd Resistance Point 93.25
1st Resistance Point 91.62
Last Price 90.00
1st Support Level 88.60
2nd Support Level 87.21

See More

52-Week High 91.85
Last Price 90.00
Fibonacci 61.8% 67.61
Fibonacci 50% 60.12
Fibonacci 38.2% 52.63
52-Week Low 28.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar